SULFAPYRIDINE
LOE ApproachingNDAORALTABLET
Approved
Mar 1939
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sulfapyridine is a small-molecule sulfonamide antibiotic approved in 1939 for oral tablet administration. Its mechanism of action and specific indications are not documented in available data, though sulfonamides historically have been used for bacterial and inflammatory conditions. The drug is a legacy product from Eli Lilly with over 80 years of clinical use.
LOE Approaching
This legacy product approaching loss of exclusivity signals a transition-phase team focused on cost management and generic transition support rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on sulfapyridine offers limited career momentum due to approaching loss of exclusivity and zero linked job openings. Professionals on this team are typically managing decline, supporting generic transition, or optimizing legacy product profitability rather than driving innovation or growth.
Brand ManagerMarket Access Manager
Worked on SULFAPYRIDINE at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.